ArticleAntioxidants (Basel, Switzerland)2026
NMR-Guided Discovery of Luvunga D: A Novel Propellane-Type Limonoid from
Bien-Thuy Bui Nguyen, Hoang-Minh Bui, Chia-Ching Liaw, Quoc-Dung Tran Huynh, Chih-Hua Chao, Duy-Hien Tran, I-Wen Lo, Thanh-Hoa Vo, Andreas Koeberle, Solveigh C Koeberle and 2 more
Abstract read
In one paragraphArticle in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Bien-Thuy Bui NguyenPh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
Hoang-Minh BuiMichael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria.
Duy-Hien TranPh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
I-Wen LoNational Research Institute of Chinese Medicine, Taipei 112026, Taiwan.
Thanh-Hoa VoDepartment of Pharmacognosy, Faculty of Pharmacy, University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
Andreas KoeberleMichael Popp Institute, Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria.ORCID 0000-0001-6269-5088 Solveigh C KoeberleInstitute of Pharmaceutical Sciences, Pharmacognosy and Excellence Field BioHealth, NAWI Graz, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-8008-494X Mei-Chuan ChenPh.D. Program in Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University, Taipei 110301, Taiwan.
Funding
FWF Austrian Science Fund 10.55776/P36299FWF Austrian Science Fund 10.55776/PAT9018824FWF Austrian Science Fund 10.55776/RIC4054324National Science and Technology Council, Republic of China NSTC111-2321-B-077-001National Science and Technology Council, Republic of China NSTC112-2321-B-077-001National Science and Technology Council, Republic of China NSTC113-2321-B-077-001
6 · The paper itselfAbstract
Recent phytochemical investigations have demonstrated that
Indexed as
antioxidant reactionsferroptosislimonoidLuvunga scandensNMR-guided
Identifiers
PMID41897547
PMCPMC13024304
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390